Natera (NTRA) Stock Insights

NTRA$391.03—
Medical - Diagnostics & ResearchLarge CapGrowth Stock
Compare
Market cap$39.64BEnterprise value—Revenue (TTM)$2.91BMarket positionTop 25%

Score

56
Neutral
Value
52
Quality
27
Growth
88

Insights

  • Revenue by product
  • Revenue by region
Revenue by product
PeriodValue
FY2018Constellation: 4844000.0, Hcs: 87171000.0, Licensing And Other: 17288000.0, Other Genetic Tests: 12263000.0, Other Product Revenues: 6650000.0, Panorama Nipt: 140932000.0, Product: 240366000.0, Qiagen: 5794000.0
FY2019License And Development Services: 16379000.0, Licensing And Other: 32447000.0, Other Licensing And Other: 10979000.0, Product: 269881000.0, Upfront License And Constellation And Paternity Services: 5089000.0
FY2020Licensing And Other: 23794000.0, Product: 367211000.0
FY2021Licensing and other: 58337000.0, Product: 567149000.0
FY2022Licensing and other: 22915000.0, Product: 797307000.0
FY2023Genetic testing services: 18300000.0, Licensing and other: 14049000.0, Oncology products: 19300000.0, Product: 1068522000.0
FY2024Licensing and other: 11837000.0, Product: 1685074000.0
FY2025Licensing and other: 10293000.0, Product: 2295820000.0
Revenue by region
PeriodValue
FY2015Americas Excluding Us: 4552000.0, Europe Middle East India And Africa: 15437000.0, U: 164952000.0, X: 5414000.0
FY2016Americas Excluding Us: 2562000.0, Europe Middle East India And Africa: 14256000.0, U: 193054000.0, X: 7202000.0
FY2017Americas Excluding Us: 3028000.0, Europe Middle East India And Africa: 13998000.0, U: 186847000.0, X: 7066000.0
FY2018Americas Excluding Us: 3472000.0, Europe Middle East India And Africa: 20866000.0, Other Geographic Areas: 7385000.0, U: 225931000.0
FY2019Americas Excluding Us: 3218000.0, Europe Middle East India And Africa: 15434000.0, Other Geographic Areas: 22830000.0, U: 260846000.0
FY2020Americas Excluding Us: 3469000.0, Europe Middle East India And Africa: 14332000.0, Other Geographic Areas: 7544000.0, U: 365660000.0
FY2021Americas, excluding U.S.: 4047000.0, Asia Pacific and Other: 10138000.0, Europe, Middle East, India, and Africa: 20429000.0, United States: 590872000.0
FY2022Americas, excluding U.S.: 3705000.0, Asia Pacific and Other: 14028000.0, Europe, Middle East, India, Africa: 16640000.0, United States: 785849000.0
FY2023Americas, excluding U.S.: 4908000.0, Asia Pacific and Other: 7216000.0, Europe, Middle East, India, Africa: 22811000.0, United States: 1047636000.0
FY2024Americas, excluding U.S.: 6620000.0, Asia Pacific and Other: 8662000.0, Europe, Middle East, India, Africa: 23884000.0, United States: 1657745000.0
FY2025Americas, excluding U.S.: 9354000.0, Asia Pacific and Other: 8014000.0, Europe, Middle East, India, and Africa: 24480000.0, United States: 2264265000.0

Natera (NTRA) Stock Insights

NTRA price $391.03 —

Ticker
NTRA
Price
$391.03
Change
—
Market cap
$39.64B
Dividend yield
0.00%
Beta
1.51
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Stocklytics score
56
Value
52
Quality
27
Growth
88

Stocklytics score rationale: value 52, quality 27, growth 88.

AI Score 30. Natera, Inc. has a high price of $378.92 with a market cap of $54.6 billion, but it shows significant financial distress with a negative net profit margin of -0.071 and a price-to-earnings ratio of -278.6

Insights

Revenue by product
PeriodValue
FY2018Constellation: 4844000.0, Hcs: 87171000.0, Licensing And Other: 17288000.0, Other Genetic Tests: 12263000.0, Other Product Revenues: 6650000.0, Panorama Nipt: 140932000.0, Product: 240366000.0, Qiagen: 5794000.0
FY2019License And Development Services: 16379000.0, Licensing And Other: 32447000.0, Other Licensing And Other: 10979000.0, Product: 269881000.0, Upfront License And Constellation And Paternity Services: 5089000.0
FY2020Licensing And Other: 23794000.0, Product: 367211000.0
FY2021Licensing and other: 58337000.0, Product: 567149000.0
FY2022Licensing and other: 22915000.0, Product: 797307000.0
FY2023Genetic testing services: 18300000.0, Licensing and other: 14049000.0, Oncology products: 19300000.0, Product: 1068522000.0
FY2024Licensing and other: 11837000.0, Product: 1685074000.0
FY2025Licensing and other: 10293000.0, Product: 2295820000.0
Revenue by region
PeriodValue
FY2015Americas Excluding Us: 4552000.0, Europe Middle East India And Africa: 15437000.0, U: 164952000.0, X: 5414000.0
FY2016Americas Excluding Us: 2562000.0, Europe Middle East India And Africa: 14256000.0, U: 193054000.0, X: 7202000.0
FY2017Americas Excluding Us: 3028000.0, Europe Middle East India And Africa: 13998000.0, U: 186847000.0, X: 7066000.0
FY2018Americas Excluding Us: 3472000.0, Europe Middle East India And Africa: 20866000.0, Other Geographic Areas: 7385000.0, U: 225931000.0
FY2019Americas Excluding Us: 3218000.0, Europe Middle East India And Africa: 15434000.0, Other Geographic Areas: 22830000.0, U: 260846000.0
FY2020Americas Excluding Us: 3469000.0, Europe Middle East India And Africa: 14332000.0, Other Geographic Areas: 7544000.0, U: 365660000.0
FY2021Americas, excluding U.S.: 4047000.0, Asia Pacific and Other: 10138000.0, Europe, Middle East, India, and Africa: 20429000.0, United States: 590872000.0
FY2022Americas, excluding U.S.: 3705000.0, Asia Pacific and Other: 14028000.0, Europe, Middle East, India, Africa: 16640000.0, United States: 785849000.0
FY2023Americas, excluding U.S.: 4908000.0, Asia Pacific and Other: 7216000.0, Europe, Middle East, India, Africa: 22811000.0, United States: 1047636000.0
FY2024Americas, excluding U.S.: 6620000.0, Asia Pacific and Other: 8662000.0, Europe, Middle East, India, Africa: 23884000.0, United States: 1657745000.0
FY2025Americas, excluding U.S.: 9354000.0, Asia Pacific and Other: 8014000.0, Europe, Middle East, India, and Africa: 24480000.0, United States: 2264265000.0

Insights · Forecast · Financials · Learn

Stocklytics home · Screener